Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19

Coronavirus disease 2019 (COVID-19) experienced an outbreak that expanded worldwide. Lopinavir/ritonavir (LPV/r), which is used effectively for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus infections, was applied for COVID-19 treatment given simila...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Liusheng, Zheng, Yuzhen, Liu, Jixian, Luo, Ruixing, Wu, Dingwang, Xu, Pengcheng, Wu, Da, Li, Xiaoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109137/
https://www.ncbi.nlm.nih.gov/pubmed/33879634
http://dx.doi.org/10.18632/aging.202860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109137/
https://www.ncbi.nlm.nih.gov/pubmed/33879634
http://dx.doi.org/10.18632/aging.202860

Ejemplares similares